Drug-company sponsorship and the Declaration of Helsinki
Publication
, Journal Article
O'Shea, JC; Tcheng, JE
Published in: The Lancet
May 2001
Duke Scholars
Published In
The Lancet
DOI
ISSN
0140-6736
Publication Date
May 2001
Volume
357
Issue
9266
Start / End Page
1448 / 1449
Publisher
Elsevier BV
Related Subject Headings
- General & Internal Medicine
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Shea, J. C., & Tcheng, J. E. (2001). Drug-company sponsorship and the Declaration of Helsinki. The Lancet, 357(9266), 1448–1449. https://doi.org/10.1016/s0140-6736(00)04604-3
O’Shea, J Conor, and James E. Tcheng. “Drug-company sponsorship and the Declaration of Helsinki.” The Lancet 357, no. 9266 (May 2001): 1448–49. https://doi.org/10.1016/s0140-6736(00)04604-3.
O’Shea JC, Tcheng JE. Drug-company sponsorship and the Declaration of Helsinki. The Lancet. 2001 May;357(9266):1448–9.
O’Shea, J. Conor, and James E. Tcheng. “Drug-company sponsorship and the Declaration of Helsinki.” The Lancet, vol. 357, no. 9266, Elsevier BV, May 2001, pp. 1448–49. Crossref, doi:10.1016/s0140-6736(00)04604-3.
O’Shea JC, Tcheng JE. Drug-company sponsorship and the Declaration of Helsinki. The Lancet. Elsevier BV; 2001 May;357(9266):1448–1449.
Published In
The Lancet
DOI
ISSN
0140-6736
Publication Date
May 2001
Volume
357
Issue
9266
Start / End Page
1448 / 1449
Publisher
Elsevier BV
Related Subject Headings
- General & Internal Medicine
- 11 Medical and Health Sciences